Brain Tumor Diagnosis And Therapeutics Market Size, Share & Trends Analysis Report By Type (Primary, Secondary), By Product, By Diagnosis (MRI, CT, PET-CT), By Therapeutics, By End Use, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 2 Business Days
Brain Tumor Diagnosis And Therapeutics Market Growth & Trends
The global brain tumor diagnosis and therapeutics market size is expected t%li%reach USD 4.94 billion in 2030 and is projected t%li%grow at a CAGR of 7.3% from 2025 t%li%2030. The market is expected t%li%pose lucrative growth over the forecast period, owing t%li%the increasing incidence of various brain cancers, particularly glioblastoma, coupled with the rising geriatric population.
Increasing Public-Private Partnerships (PPPs) in the health sector, which are modernizing diagnostic imaging and radiology services, are supporting the expansion of this industry. Emerging technologies like Sodium Magnetic Resonance Imaging(23Na MRI), Positron Emission Tomography (PET), and Chemical Exchange Saturation Transfer (CEST) are used t%li%detect the response of brain tumors in multicenter clinical trial settings. In addition, these technologies are helpful in quantitatively imaging tumor response t%li%therapies, thereby promoting their use during treatment.
These technologies have the potential t%li%extend MRI beyond anatomical imaging by providing information on physiology and cellular metabolism, thereby increasing the efficiency of diagnosis. Hence, the market is expected t%li%witness productive growth over the forecast period.
Moreover, ongoing research in molecular diagnostics t%li%understand cell biology at the cellular level of malignancy and identification of gene mutations associated with malignancy is anticipated t%li%significantly contribute toward the growth of the industry.
On the other hand, the high cost of diagnosing brain tumors, which ranges from USD 450 t%li%12,200, is likely t%li%hinder the growth of the global brain tumor diagnosis market.
Brain Tumor Diagnosis And Therapeutics Market Report Highlights
Brain Tumor Diagnosis And Therapeutics Market Growth & Trends
The global brain tumor diagnosis and therapeutics market size is expected t%li%reach USD 4.94 billion in 2030 and is projected t%li%grow at a CAGR of 7.3% from 2025 t%li%2030. The market is expected t%li%pose lucrative growth over the forecast period, owing t%li%the increasing incidence of various brain cancers, particularly glioblastoma, coupled with the rising geriatric population.
Increasing Public-Private Partnerships (PPPs) in the health sector, which are modernizing diagnostic imaging and radiology services, are supporting the expansion of this industry. Emerging technologies like Sodium Magnetic Resonance Imaging(23Na MRI), Positron Emission Tomography (PET), and Chemical Exchange Saturation Transfer (CEST) are used t%li%detect the response of brain tumors in multicenter clinical trial settings. In addition, these technologies are helpful in quantitatively imaging tumor response t%li%therapies, thereby promoting their use during treatment.
These technologies have the potential t%li%extend MRI beyond anatomical imaging by providing information on physiology and cellular metabolism, thereby increasing the efficiency of diagnosis. Hence, the market is expected t%li%witness productive growth over the forecast period.
Moreover, ongoing research in molecular diagnostics t%li%understand cell biology at the cellular level of malignancy and identification of gene mutations associated with malignancy is anticipated t%li%significantly contribute toward the growth of the industry.
On the other hand, the high cost of diagnosing brain tumors, which ranges from USD 450 t%li%12,200, is likely t%li%hinder the growth of the global brain tumor diagnosis market.
Brain Tumor Diagnosis And Therapeutics Market Report Highlights
- Advancements in diagnostic imaging technologies have significantly enhanced the capabilities within the market
- The primary segment dominated the market and accounted for a share of 62.7% in 2024
- Stains & varnishes led the market and accounted for a share of 25.7% in 2024
- CT scan dominated the market with a revenue share of 25.8% in 2024
- Surgery held the largest market share of 35.6% in 2024
- Oncology treatment centers held the largest market share of 48.5% in 2024
- North America brain tumor diagnosis and therapeutics market dominated the global market with a revenue share of 41.9% in 2024
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Product
1.2.3. Diagnosis
1.2.4. Therapeutics
1.2.5. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: TYPE BUSINESS ANALYSIS
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Primary
4.4.1. Primary Market, 2018 - 2030 (USD Million)
4.4.2. Meningioma
4.4.2.1. Meningioma Market, 2018 - 2030 (USD Million)
4.4.3. Gliomas
4.4.3.1. Gliomas Market, 2018 - 2030 (USD Million)
4.4.4. Astrocytomas
4.4.4.1. Astrocytomas Market, 2018 - 2030 (USD Million)
4.4.5. Pituitary Tumors
4.4.5.1. Pituitary Tumors Market, 2018 - 2030 (USD Million)
4.4.6. Others
4.4.6.1. Others Market, 2018 - 2030 (USD Million)
4.5. Secondary
4.5.1. Secondary Market, 2018 - 2030 (USD Million)
CHAPTER 5. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: PRODUCT BUSINESS ANALYSIS
5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Stains & Varnishes
5.4.1. Stains & Varnishes Market, 2018 - 2030 (USD Million)
5.5. Shellacs
5.5.1. Shellacs Market, 2018 - 2030 (USD Million)
5.6. Lacquers
5.6.1. Lacquers Market, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 6. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: DIAGNOSIS BUSINESS ANALYSIS
6.1. Diagnosis Market Share, 2024 & 2030
6.2. Diagnosis Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Diagnosis, 2018 to 2030 (USD Million)
6.4. MRI
6.4.1. MRI Market, 2018 - 2030 (USD Million)
6.5. CT Scan
6.5.1. CT Scan Market, 2018 - 2030 (USD Million)
6.6. Tissue Sampling
6.6.1. Tissue Sampling Market, 2018 - 2030 (USD Million)
6.7. PET-CT scan
6.7.1. PET-CT scan Market, 2018 - 2030 (USD Million)
6.8. Cerebral Arteriogram
6.8.1. Cerebral Arteriogram Market, 2018 - 2030 (USD Million)
6.9. Lumbar Puncture
6.9.1. Lumbar Puncture Market, 2018 - 2030 (USD Million)
6.10. Molecular Testing
6.10.1. Molecular Testing Market, 2018 - 2030 (USD Million)
6.11. EEG
6.11.1. EEG Market, 2018 - 2030 (USD Million)
6.12. Others
6.12.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 7. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: THERAPEUTICS BUSINESS ANALYSIS
7.1. Therapeutics Market Share, 2024 & 2030
7.2. Therapeutics Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Therapeutics, 2018 to 2030 (USD Million)
7.4. Surgery
7.4.1. Surgery Market, 2018 - 2030 (USD Million)
7.5. Radiation Therapy
7.5.1. Radiation Therapy Market, 2018 - 2030 (USD Million)
7.6. Chemotherapy
7.6.1. Chemotherapy Market, 2018 - 2030 (USD Million)
7.7. Immunotherapy
7.7.1. Immunotherapy Market, 2018 - 2030 (USD Million)
7.8. Targeted Therapy
7.8.1. Targeted Therapy Market, 2018 - 2030 (USD Million)
7.9. Others
7.9.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 8. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: END USE BUSINESS ANALYSIS
8.1. End Use Market Share, 2024 & 2030
8.2. End Use Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Hospitals
8.4.1. Hospitals Market, 2018 - 2030 (USD Million)
8.5. Oncology Treatment Centers
8.5.1. Oncology Treatment Centers Market, 2018 - 2030 (USD Million)
8.6. Others
8.6.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 9. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. North America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.4.2. U.S.
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Framework
9.4.2.3. Competitive Insights
9.4.2.4. U.S. Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Framework
9.4.3.3. Competitive Insights
9.4.3.4. Canada Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Framework
9.4.4.3. Competitive Insights
9.4.4.4. Mexico Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5. Europe
9.5.1. Europe Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.5.2. UK
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Framework
9.5.2.3. Competitive Insights
9.5.2.4. UK Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Framework
9.5.3.3. Competitive Insights
9.5.3.4. Germany Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.4. France
9.5.4.1. Key Country Dynamics
9.5.4.2. Regulatory Framework
9.5.4.3. Competitive Insights
9.5.4.4. France Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.5. Italy
9.5.5.1. Key Country Dynamics
9.5.5.2. Regulatory Framework
9.5.5.3. Competitive Insights
9.5.5.4. Italy Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key Country Dynamics
9.5.6.2. Regulatory Framework
9.5.6.3. Competitive Insights
9.5.6.4. Spain Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.7. Norway
9.5.7.1. Key Country Dynamics
9.5.7.2. Regulatory Framework
9.5.7.3. Competitive Insights
9.5.7.4. Norway Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.8. Denmark
9.5.8.1. Key Country Dynamics
9.5.8.2. Regulatory Framework
9.5.8.3. Competitive Insights
9.5.8.4. Denmark Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.9. Sweden
9.5.9.1. Key Country Dynamics
9.5.9.2. Regulatory Framework
9.5.9.3. Competitive Insights
9.5.9.4. Sweden Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.6.2. Japan
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Framework
9.6.2.3. Competitive Insights
9.6.2.4. Japan Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.3. China
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Framework
9.6.3.3. Competitive Insights
9.6.3.4. China Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.4. India
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Framework
9.6.4.3. Competitive Insights
9.6.4.4. India Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.5. South Korea
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Framework
9.6.5.3. Competitive Insights
9.6.5.4. South Korea Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.6. Australia
9.6.6.1. Key Country Dynamics
9.6.6.2. Regulatory Framework
9.6.6.3. Competitive Insights
9.6.6.4. Australia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key Country Dynamics
9.6.7.2. Regulatory Framework
9.6.7.3. Competitive Insights
9.6.7.4. Thailand Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.7. Latin America
9.7.1. Latin America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key Country Dynamics
9.7.2.2. Regulatory Framework
9.7.2.3. Competitive Insights
9.7.2.4. Brazil Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key Country Dynamics
9.7.3.2. Regulatory Framework
9.7.3.3. Competitive Insights
9.7.3.4. Argentina Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8. MEA
9.8.1. MEA Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key Country Dynamics
9.8.2.2. Regulatory Framework
9.8.2.3. Competitive Insights
9.8.2.4. South Africa Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key Country Dynamics
9.8.3.2. Regulatory Framework
9.8.3.3. Competitive Insights
9.8.3.4. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key Country Dynamics
9.8.4.2. Regulatory Framework
9.8.4.3. Competitive Insights
9.8.4.4. UAE Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key Country Dynamics
9.8.5.2. Regulatory Framework
9.8.5.3. Competitive Insights
9.8.5.4. Kuwait Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
10.5.1. Amgen Inc.
10.5.1.1. Overview
10.5.1.2. Financial Performance
10.5.1.3. Product Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. AstraZeneca
10.5.2.1. Overview
10.5.2.2. Financial Performance
10.5.2.3. Product Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. Bayer Corporation
10.5.3.1. Overview
10.5.3.2. Financial Performance
10.5.3.3. Product Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. GE HealthCare
10.5.4.1. Overview
10.5.4.2. Financial Performance
10.5.4.3. Product Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. F. Hoffmann-La Roche Ltd
10.5.5.1. Overview
10.5.5.2. Financial Performance
10.5.5.3. Product Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. Eisai Co., Ltd.
10.5.6.1. Overview
10.5.6.2. Financial Performance
10.5.6.3. Product Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. Bristol-Myers Squibb Company
10.5.7.1. Overview
10.5.7.2. Financial Performance
10.5.7.3. Product Benchmarking
10.5.7.4. Strategic Initiatives
10.5.8. Pfizer Inc.
10.5.8.1. Overview
10.5.8.2. Financial Performance
10.5.8.3. Product Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. Shimadzu Corporation
10.5.9.1. Overview
10.5.9.2. Financial Performance
10.5.9.3. Product Benchmarking
10.5.9.4. Strategic Initiatives
10.5.10. Siemens Healthineers AG
10.5.10.1. Overview
10.5.10.2. Financial Performance
10.5.10.3. Product Benchmarking
10.5.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Product
1.2.3. Diagnosis
1.2.4. Therapeutics
1.2.5. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: TYPE BUSINESS ANALYSIS
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Primary
4.4.1. Primary Market, 2018 - 2030 (USD Million)
4.4.2. Meningioma
4.4.2.1. Meningioma Market, 2018 - 2030 (USD Million)
4.4.3. Gliomas
4.4.3.1. Gliomas Market, 2018 - 2030 (USD Million)
4.4.4. Astrocytomas
4.4.4.1. Astrocytomas Market, 2018 - 2030 (USD Million)
4.4.5. Pituitary Tumors
4.4.5.1. Pituitary Tumors Market, 2018 - 2030 (USD Million)
4.4.6. Others
4.4.6.1. Others Market, 2018 - 2030 (USD Million)
4.5. Secondary
4.5.1. Secondary Market, 2018 - 2030 (USD Million)
CHAPTER 5. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: PRODUCT BUSINESS ANALYSIS
5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Stains & Varnishes
5.4.1. Stains & Varnishes Market, 2018 - 2030 (USD Million)
5.5. Shellacs
5.5.1. Shellacs Market, 2018 - 2030 (USD Million)
5.6. Lacquers
5.6.1. Lacquers Market, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 6. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: DIAGNOSIS BUSINESS ANALYSIS
6.1. Diagnosis Market Share, 2024 & 2030
6.2. Diagnosis Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Diagnosis, 2018 to 2030 (USD Million)
6.4. MRI
6.4.1. MRI Market, 2018 - 2030 (USD Million)
6.5. CT Scan
6.5.1. CT Scan Market, 2018 - 2030 (USD Million)
6.6. Tissue Sampling
6.6.1. Tissue Sampling Market, 2018 - 2030 (USD Million)
6.7. PET-CT scan
6.7.1. PET-CT scan Market, 2018 - 2030 (USD Million)
6.8. Cerebral Arteriogram
6.8.1. Cerebral Arteriogram Market, 2018 - 2030 (USD Million)
6.9. Lumbar Puncture
6.9.1. Lumbar Puncture Market, 2018 - 2030 (USD Million)
6.10. Molecular Testing
6.10.1. Molecular Testing Market, 2018 - 2030 (USD Million)
6.11. EEG
6.11.1. EEG Market, 2018 - 2030 (USD Million)
6.12. Others
6.12.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 7. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: THERAPEUTICS BUSINESS ANALYSIS
7.1. Therapeutics Market Share, 2024 & 2030
7.2. Therapeutics Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Therapeutics, 2018 to 2030 (USD Million)
7.4. Surgery
7.4.1. Surgery Market, 2018 - 2030 (USD Million)
7.5. Radiation Therapy
7.5.1. Radiation Therapy Market, 2018 - 2030 (USD Million)
7.6. Chemotherapy
7.6.1. Chemotherapy Market, 2018 - 2030 (USD Million)
7.7. Immunotherapy
7.7.1. Immunotherapy Market, 2018 - 2030 (USD Million)
7.8. Targeted Therapy
7.8.1. Targeted Therapy Market, 2018 - 2030 (USD Million)
7.9. Others
7.9.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 8. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: END USE BUSINESS ANALYSIS
8.1. End Use Market Share, 2024 & 2030
8.2. End Use Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Hospitals
8.4.1. Hospitals Market, 2018 - 2030 (USD Million)
8.5. Oncology Treatment Centers
8.5.1. Oncology Treatment Centers Market, 2018 - 2030 (USD Million)
8.6. Others
8.6.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 9. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. North America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.4.2. U.S.
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Framework
9.4.2.3. Competitive Insights
9.4.2.4. U.S. Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Framework
9.4.3.3. Competitive Insights
9.4.3.4. Canada Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Framework
9.4.4.3. Competitive Insights
9.4.4.4. Mexico Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5. Europe
9.5.1. Europe Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.5.2. UK
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Framework
9.5.2.3. Competitive Insights
9.5.2.4. UK Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Framework
9.5.3.3. Competitive Insights
9.5.3.4. Germany Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.4. France
9.5.4.1. Key Country Dynamics
9.5.4.2. Regulatory Framework
9.5.4.3. Competitive Insights
9.5.4.4. France Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.5. Italy
9.5.5.1. Key Country Dynamics
9.5.5.2. Regulatory Framework
9.5.5.3. Competitive Insights
9.5.5.4. Italy Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key Country Dynamics
9.5.6.2. Regulatory Framework
9.5.6.3. Competitive Insights
9.5.6.4. Spain Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.7. Norway
9.5.7.1. Key Country Dynamics
9.5.7.2. Regulatory Framework
9.5.7.3. Competitive Insights
9.5.7.4. Norway Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.8. Denmark
9.5.8.1. Key Country Dynamics
9.5.8.2. Regulatory Framework
9.5.8.3. Competitive Insights
9.5.8.4. Denmark Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.9. Sweden
9.5.9.1. Key Country Dynamics
9.5.9.2. Regulatory Framework
9.5.9.3. Competitive Insights
9.5.9.4. Sweden Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.6.2. Japan
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Framework
9.6.2.3. Competitive Insights
9.6.2.4. Japan Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.3. China
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Framework
9.6.3.3. Competitive Insights
9.6.3.4. China Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.4. India
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Framework
9.6.4.3. Competitive Insights
9.6.4.4. India Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.5. South Korea
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Framework
9.6.5.3. Competitive Insights
9.6.5.4. South Korea Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.6. Australia
9.6.6.1. Key Country Dynamics
9.6.6.2. Regulatory Framework
9.6.6.3. Competitive Insights
9.6.6.4. Australia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key Country Dynamics
9.6.7.2. Regulatory Framework
9.6.7.3. Competitive Insights
9.6.7.4. Thailand Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.7. Latin America
9.7.1. Latin America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key Country Dynamics
9.7.2.2. Regulatory Framework
9.7.2.3. Competitive Insights
9.7.2.4. Brazil Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key Country Dynamics
9.7.3.2. Regulatory Framework
9.7.3.3. Competitive Insights
9.7.3.4. Argentina Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8. MEA
9.8.1. MEA Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key Country Dynamics
9.8.2.2. Regulatory Framework
9.8.2.3. Competitive Insights
9.8.2.4. South Africa Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key Country Dynamics
9.8.3.2. Regulatory Framework
9.8.3.3. Competitive Insights
9.8.3.4. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key Country Dynamics
9.8.4.2. Regulatory Framework
9.8.4.3. Competitive Insights
9.8.4.4. UAE Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key Country Dynamics
9.8.5.2. Regulatory Framework
9.8.5.3. Competitive Insights
9.8.5.4. Kuwait Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
10.5.1. Amgen Inc.
10.5.1.1. Overview
10.5.1.2. Financial Performance
10.5.1.3. Product Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. AstraZeneca
10.5.2.1. Overview
10.5.2.2. Financial Performance
10.5.2.3. Product Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. Bayer Corporation
10.5.3.1. Overview
10.5.3.2. Financial Performance
10.5.3.3. Product Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. GE HealthCare
10.5.4.1. Overview
10.5.4.2. Financial Performance
10.5.4.3. Product Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. F. Hoffmann-La Roche Ltd
10.5.5.1. Overview
10.5.5.2. Financial Performance
10.5.5.3. Product Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. Eisai Co., Ltd.
10.5.6.1. Overview
10.5.6.2. Financial Performance
10.5.6.3. Product Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. Bristol-Myers Squibb Company
10.5.7.1. Overview
10.5.7.2. Financial Performance
10.5.7.3. Product Benchmarking
10.5.7.4. Strategic Initiatives
10.5.8. Pfizer Inc.
10.5.8.1. Overview
10.5.8.2. Financial Performance
10.5.8.3. Product Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. Shimadzu Corporation
10.5.9.1. Overview
10.5.9.2. Financial Performance
10.5.9.3. Product Benchmarking
10.5.9.4. Strategic Initiatives
10.5.10. Siemens Healthineers AG
10.5.10.1. Overview
10.5.10.2. Financial Performance
10.5.10.3. Product Benchmarking
10.5.10.4. Strategic Initiatives
